Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01574612 · ClinicalTrials.gov registry record · Phase 3

Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old

A Phase 3 study of Herpes Labialis, sponsored by Meda Pharmaceuticals.

Completed
Registry status
Phase 3
Development phase
54
Enrollment target
10
Study locations

NCT01574612 is a Phase 3 study of Herpes Labialis that has completed, run by Meda Pharmaceuticals. The registered enrollment target is 54 participants, below the 1,054-participant average among 6 other Herpes Labialis trials with a reported enrollment target (95% lower). The trial reports 10 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01574612, a Phase 3 study of Herpes Labialis, has completed, sponsored by Meda Pharmaceuticals.

COMPLETED
Registry status
Phase 3
Development phase
54 participants
Enrollment target
10
Study locations

Study Summary

To test the safety of Xerese (acyclovir and hydrocortisone)Cream 5%/1% for the treatment of recurrent cold sores in children ages 6-11yrs after 5 days of treatment.

Conditions Studied

Herpes Labialis

Interventions

  • DRUG acyclovir/hydrocortisone cream

Study Locations (10)

Florida

  • Sunshine Research Center - Opa-locka
  • Altus Rsearch,INC - West Palm Beach

California

  • MCS Clinical Trials - Los Angeles

Illinois

  • Provident Clincal Research - Addison

Kentucky

  • Central Kentucky Research - Lexington

New York

  • Rochester Clinical Research - Rochester

North Carolina

  • PGM Research of Winston-Salem, LLC - Winston-Salem

Rhode Island

  • Clinical Partners LLC - Johnston

Texas

  • Corsicana Medical Research,PNC - Corsicana

Trial Details

FieldValue
Enrollment Target 54 participants
Start Date 2012-03
Est. Completion 2013-02
Phase Phase 3

Sponsor

Meda Pharmaceuticals

19 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01574612

The ClinicalTrials.gov registry entry for NCT01574612 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,054-participant average among 6 other Herpes Labialis trials with a reported enrollment target (95% lower). The listed sponsor is Meda Pharmaceuticals, which has 19 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Herpes Labialis appearing as the primary indexed condition, and to 1 intervention - of which acyclovir/hydrocortisone cream is the first listed.

NCT01574612 reports 10 study locations spanning 9 distinct geographic areas - top geographies include Florida, California, Illinois.

Frequently Asked Questions

What is clinical trial NCT01574612 about?

NCT01574612 is a clinical study titled "Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old". To test the safety of Xerese (acyclovir and hydrocortisone)Cream 5%/1% for the treatment of recurrent cold sores in children ages 6-11yrs after 5 days of treatment.

What is the current status of trial NCT01574612?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 54 participants. The study started on 2012-03. Estimated completion is 2013-02.

What conditions does trial NCT01574612 study?

This clinical trial studies the following conditions: Herpes Labialis.

What interventions are being tested in trial NCT01574612?

The interventions under investigation include: acyclovir/hydrocortisone cream (DRUG).

Who is sponsoring clinical trial NCT01574612?

This trial is sponsored by Meda Pharmaceuticals, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01574612 being conducted?

This trial has 10 study locations across California, Florida, Illinois, Kentucky, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Herpes Labialis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Herpes Labialis

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.